Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement

Healthcare & Fitness


Burns treatment biotech soars 22pc on record sales month

PolyNovo has surpassed $5 million in monthly sales for the first time after expanding its US sales team.

  • Yolanda Redrup

Body scanning biz Evolt 360 picks up Regal, Soul Patts

Body composition scanning business Evolt 360 has picked up a handful of institutional investors, as part of a $12 million private funding round via Bell Potter.Β 

  • Anthony Macdonald, Sarah Thompson and Kanika Sood

This Month

Blood biotech Aegros chases $300m-plus float, raising first

Blood plasma biotech Aegros has mapped out plans for $300 million-plus listing on the ASX boards next year, in a bid to lure investors into two nera term private funding rounds.Β 

  • Anthony Macdonald, Sarah Thompson and Kanika Sood

Vet meds biz AVet Health raising $10m to acquire Zoetis products

Sydney-based veterinary pharmaceutical company AVet Health has tapped MST Financial to round up $10 million to buy a basket of products from global animal healthcare giant Zoetis.

  • Anthony Macdonald, Sarah Thompson and Kanika Sood

Telehealth biz InstantScripts hunts for new owner; $200m sale tipped

The doctor’s recommended a new owner for InstantScripts, and the four-year-old telehealth business has brought in Lazard Australia to find one.

  • Anthony Macdonald, Sarah Thompson and Kanika Sood

Osteoarthritis trial results propel Paradigm shares 19pc

Paradigm’s repurposed drug to treat osteoarthritis is showing early signs of having the potential to halt or reverse the progress of the disease.

  • Yolanda Redrup

Next Capital gets Compare Club in $100m-plus deal, E&P on ticket

Mid-market buyout firm Next Capital has gone shopping for insurance against cost of living pressures.

  • Anthony Macdonald, Sarah Thompson and Kanika Sood


Bubs in China JV to smooth way for Chinese-labelled formula

Bubs is having an each-way bet in China, with a joint venture deal with China’s HUG to open up the remaining 80pc of a $40b infant formula market.

  • Simon Evans

Alzheimer’s progression slowed by drug in major trial

Eisai and partner Biogen say their drug has slowed the pace of cognitive decline in people with early disease by 27 per cent when compared with a placebo.

  • Robert Langreth

Rich Lister Bruce Mathieson caught up in Ellume collapse

Pubs baron Bruce Mathieson and Pure Asset Management are some of the investors tied up in the collapse of Ellume, which owes creditors and staff $140 million.

  • Yolanda Redrup, Sarah Thompson, Kanika Sood and Anthony Macdonald

Sigma’s tech nightmare nearly over, books net loss for last half

Sigma Healthcare shares slumped 7 per cent on Monday after losses at the pharmaceutical wholesaler widened over the last half.

  • Jessica Sier

Ramsay shares slide as KKR talks officially dead

Australia’s biggest private hospital operator says it is still β€œopen” to a buyout deal, but not one with a similar value to KKR’s latest effort.

  • Simon Evans

When you exercise is key to losing fat and gaining muscle

Women burn more fat if they exercise in the morning, but men burn more in afternoon workouts. Weight training works better later in the day for both sexes.

  • Gretchen Reynolds

New Wesfarmers health boss plans for growth

Emily Amos is just five months into the top job at what will one day be $10 billion division for the WA-based conglomerate.

  • Carrie LaFrenz

Research biz George Clinical talks up 30pc plus rev, earnings growth

Clinical research is a hot game - just ask the up-for-sale George Clinical.Β 

  • Anthony Macdonald, Sarah Thompson and Kanika Sood

CSL wins reprieve in the battle for Mexican donors

In a long-running legal battle against the US border protection agency, it appears CSL can finally welcome back Mexican donations.

  • Carrie LaFrenz

KKR turns the screws on its target Ramsay

After the better part of two years stalking the private hospital operator, KKR & Co is still empty-handed. Ramsay needs to now focus on its business.

  • Carrie LaFrenz

Cancer biotech hunts $50m as it kicks off phase-two trial

Aucentra Therapeutics has doubled the size of its capital raise amid interest from investors in its CDK4/6 inhibitor drug.

  • Yolanda Redrup

I wore a glucose tracker for two weeks and this is what I learnt

I am not overweight, I exercise and I thought my health was just fine. But it turns out, I have sugar problem.

  • Boudicca Fox-Leonard

Small-cap biotech makes pancreatic cancer breakthrough

Noxopharm has made a promising pre-clinical breakthrough with the help of UNSW, showing a new molecule is capable of killing pancreatic cancer cells.

  • Yolanda Redrup